Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation

Leukemia

Volumn 14, Issue 6, 2000, Pages 1006-1013

  Thomas, X ^a   Dombret, H ^b   Cordonnier, C ^c   Pigneux, A ^d   Gardin, C ^e   Guerci, A ^f   Vekhoff, A ^g   Sadoun, A ^h   Stamatoullas, A ⁱ   Fegueux, N ^j   Maloisel, F ^k   Cahn, J Y ^l   Reman, O ^m   Gratecos, N ⁿ   Berthou, C ^o   Huguet, F ^p   Kotoucek, P ^q   Travade, P ^r   Buzyn, A ^s   De Revel, T ^t   Vilque, J P ^u   Naccache, P ^v   Chomienne, C ^b   Degos, L ^b   Fenaux, P ^w   more..

^a EDOUARD HERRIOT HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e BEAUJON HOSPITAL   (France)

^f CHU NANCY BRABOIS   (France)

^g HÔTEL DIEU   (France)

^h University of Poitiers   (France)

ⁱ CENTRE HENRI BECQUEREL   (France)

^j LAPEYRONIE HOSPITAL   (France)

^k HÔPITAL DE HAUTEPIERRE   (France)

^l UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^m Centre de Gerontologie Georges CLEMENCEAU   (France)

ⁿ CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^o BREST UNIVERSITY HOSPITAL   (France)

^p CHU PURPAN   (France)

^q Department of Hematology   (Slovakia)

^r HÔTEL DIEU   (France)

^s HÔPITAL NECKER ENFANTS MALADES   (France)

^t PERCY MILITARY HOSPITAL   (France)

^u SERVICE DE DERMATOLOGIE   (France)

^v INSTITUT GUSTAVE ROUSSY   (France)

^w LILLE UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Acute leukemia; Acute promyelocytic leukemia; Relapse; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; HLA ANTIGEN; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGRAFT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BONE MARROW APLASIA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0034046084     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401800     Document Type: Article

References (42)

1. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZH. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.
2. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood 1990; 76: 1704-1709.
3. Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, Bordessoule D, Sadoun A, Tiberghien P, Fegueux N, Daniel MT, Chomienne C, Degos L. All-trans retinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. Blood 1992; 80: 2176-2181,
4. Warrell RP, Frankel SR, Miller WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubovski A, Gabrilove J, Gordon MS, Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). New Engl J Med 1991; 324: 1385-1393.
5. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, Huebner G, Bauters F, Fegueux N, Fey M, Sanz M, Lowenberg B, Maloisel F, Auzanneau G, Sadoun A, Gardin C, Bastion Y, Ganser A, Jacky E, Dombret H, Chastang C, Degos L, and the European APL 91 Group. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241-3249.
6. Thomas X, Anglaret B, Thiebaut A, Belhabri A, Treille-Ritouet D, Fiere D, Archimbaud E. Improvement of prognosis in refractory and relapsed acute promyelocytic leukemia over recent years: the role of all-trans retinoic acid therapy. Ann Hematol 1997; 75: 195-200.
7. Cortes JE, Kantarjian H, O'Brien S, Robertson LE, Koller C, Hirsh-Ginsberg C, Stass S, Keating M, Estev E. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia. Cancer 1994; 73: 2946-2952.
8. Thomas ED, Buckner CD, Clift RA, Fefer A, Johnson FL, Neiman PE, Sale GE, Sanders JE, Singer JW, Shulman H, Storb R, Weiden PL. Marrow transplantation for acute nonlymphoblastic leukemia in first remission. New Engl J Med 1979; 301: 597-599.
9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR. A variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol 1980; 44: 169-170.
10. Castaigne S, Balitrand N, De Thé H, Dejean A, Degos L, Chomienne C. A PML/retinoid acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 1992; 79: 3110-3115.
11. Fenaux P, Chastang C, Chevret C, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Cony Makhoul P, Travade P, Solary E, Fegueux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L for the European APL group. A randomized comparison of all-trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999; 94: 1192-1200.
12. Cordonnier C, Dreyfus F, Casassus P, Leblond V, Pesce A, Teilletthibault F, Colombat P, Troussard X, Dombret H, Gouault M, Jouault H, Kuentz M, Karianakis G, Vernant JP. Progressive induction for prevention of disseminated intravascular coagulation in acute promyelocytic leukaemia: preliminary results. In: Barbui T, Falanga A, Minetti B, Corini S, Tognoni G, Donati MB (eds). Bergamo Spring Conferences on Haematology. Infections and Haemorrhage in Acute Leukaemia. John Libbey Eurotext: Paris, 1989, pp 81-87.
13. Archimbaud E, Leblond V, Michallet M, Cordonnier C, Fenaux P, Travade P, Dreyfus D, Jaubert J, Devaux Y, Fiere D. Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia. Blood 1991; 77: 1894-1900.
14. Ellison RR, Holland JF, Weil M, Jacquillat C, Boiron M, Bernard J, Sawitsky A, Rosner F, Gussoff B, Silver RT, Karanas A, Cuttner J, Spurr CL, Hayes DM, Bloom J, Leone LA, Haurani F, Kyle R, Hutchison JL, Forcier RJ, Moon JH. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 1968; 32: 507-523.
15. Preisler HD. Failure of remission induction in acute myelocytic leukemia. Med Pediatr Oncol 1978; 4: 275-276.
16. World Health Organization Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication: 48 WHO-Geneva, 1979.
17. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Cox DR. Regression models and life tables. JR Stat Soc B 1972; 34: 187-220.
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
20. Gorin NC, Labopin M, Meloni G, Korbling M, Carella A, Herve P, Burnett A, Rizzoli V, Alessandrino EP, Bjorkstrand B, Ferrant A, Löwenberg B, Coser P, Simonsson B, Helbig W, Brunet Mauri S, Verdonck LF, Iriondi A, Polli E, Colombat P, Franklin IM, Souillet G, Willemze R. Autologous bone marrow transplantation for acute myeloid leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT). Leukemia 1991; 5: 896-904.
21. Mandelli F, Labopin M, Granena A, Iriondo A, Prentice G, Bacigalupo A, Sierra J, Meloni G, Frassoni F, Goldman J, Gratwohl A, Gorin NC, and EBMT. European survey of bone marrow transplantation in acute promyelocytic leukemia (M3). Bone Marrow Transplant 1994; 14: 293-298.
22. Stein AS, O'Donell MR, Chai A, Schmidt GM, Nademanee A, Parker PM, Smith EP, Snyder DS, Molina A, Stepan DE, Spielberger R, Somlo G, Margolin KA, Vora N, Lipsett J, Lee J, Niland J, Forman SJ. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. J Clin Oncol 1996; 14: 2206-2216.
23. Diverio D, Pandolfi PP, Rossi V, Biondi A, Pelicci PG, Lo Coco F. Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia 1994; 8: 1105-1107.
24. Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RARα fusion gene. Blood 1997; 90: 1321-1325.
25. Roman J, Martin C, Torres A, Jimenez MA, Andres P, Flores R, de la Torre MJ, Sanchez J, Serrano J, Falcon M. Absence of detectable PML-RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Bone Marrow Transplant 1997; 19: 679-683.
26. Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C. Management of acute promyelocytic leukemia relapse in the ATRA era. Haematologica 1998; 83: 714-717.
27. Slack JL. Recent advances in the biology and treatment of acute promyelocytic leukemia. Proc Am Soc Clin Oncol 1998; 17: 54-65.
28. Demirer T, Buckner CD, Appelbaum FR, Petersen FB, Rowley S, Weaver CH, Lilleby K, Sanders J, Chauncey T, Storb R, Schiffman K, Benyunes MC, Fefer A, Montgomery P, Bensinger WI. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 1995; 15: 915-922.
29. Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, Löwenberg B, Verdonck LF, de Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990; 75: 1606-1614.
30. Grimwade D. The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease. Br J Haematol 1999; 106: 591-613.
31. Sanz MA, de la Rubia J, Bonanad S, Barragan E, Sempere A, Martin G, Martinez JA, Jimenez C, Cervera J, Bolufer P, Sanz GF. Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft? Leukemia 1998; 12: 992-995.
32. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podesta M, Celesti L, Chimirri F, Abate M, Vassallo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti AM, van den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitors cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.
33. Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J, Wiernik PH. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study. Leukemia 1994; 8: 1108-1112.
34. Sierra J, Brunet S, Granena A, Olive T, Bueno J, Ribera JM, Petit J, Besses C, Llorente A, Guardia R, Macia J, Rovira M, Badell I, Vela E, Diaz de Heredia C, Vivancos P, Carreras E, Feliu E, Montserrat E, Julia A, Cubells J, Rozman C, Domingo A, Ortega JJ. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation. J Clin Oncol 1996; 14: 1353-1363.
35. Jourdan E, Maraninchi D, Reiffers J, Gluckman E, Rio B, Jouet JP, Michallet M, Molina L, Archimbaud E, Harousseau JL, Ifrah N, Attal M, Guilhot F, Kuentz M, Guyotat D, Pico JL, Dauriac C, Legros M, Dreyfus F, Bordigoni P, Leblond V, Gratecos N, Varet B. Auzaneau C, Tilly H, Vilmer E, Bardou VJ, Blaise D for the Société Française de Greffe de Moelle (SFGM). Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Bone Marrow Transplant 1997; 19: 875-881.
36. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, De Blasio A, Levine K, Evans RM, Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor α clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 1992; 89: 2694-2698.
37. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437-1438.
38. Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jang GS, Zhang FQ, Chai JR, Wang ZY, Waxman S, Chen Z, Chen SJ. Acute promyelocytic leukemia: relevance of two major PML-RARα isoforms and detection of minimal residual disease by retrotransferase-polymerase chain reaction. Blood 1993; 82: 1264-1269.
39. Grimwade D, Jamal R, Goulden N, Kempski H, Mastrangelo S, Veys P. Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid. Br J Haematol 1998; 103: 559-562.
40. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. New Engl J Med 1998; 339: 1341-1348.
41. Lo Coco F, Diverio D, Avvisati G, Petti MC, Meloni G, Pogliani EM, Biondi A, Rossi G, Carlo-Stella C, Selleri C, Martino B, Specchia G, Mandelli F. Therapy of molecular relapse in acute promyelocytic leukemia. Blood 1999; 94: 2225-2229.
42. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354-3360.